High-throughput screening reveals NT-2 inhibits protein synthesis in human cells, suggesting novel therapeutic applications.
Translation inhibitors are invaluable for probing ribosome function and therapeutic applications, but systematic discovery in human systems is limited by the lack of scalable, screening-compatible cell-free platforms. Here, we establish a robust high-throughput screening using human lysates that bypasses cellular cytotoxic effects. After screening ~28,000 small molecules, we identified known and novel translation inhibitors, including NT-2, a trichothecene mycotoxin produced by the pathogenic Fusarium sporotrichioides. NT-2 suppressed protein synthesis in human cells and yeast lysates, while sparing translation in bacteria and intact yeast cells. Cryo-EM at 1.72 Angstrom revealed NT-2 bound at the peptidyl transferase center of the human 60S ribosome, confirming NT-2 as a eukaryote-specific elongation inhibitor that engages ribosomes in a dormant, SERBP1-bound state. Together, these results expose NT-2 as a previously unrecognized environmental inhibitor of mammalian protein synthesis and demonstrate the power of cell-free translation screening to reveal new inhibitors with unexpected ribosome fates.
No takes yet. Share an insight, caveat, or question.
Schwaller et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: